Eric Lefkofsky, Tempus and the Rise of Data-Enabled Precision Medicine

Eric Lefkofsky is an American entrepreneur who co-founded Tempus where he is a Chief Executive Officer. He was born 48 years ago to Bill, an engineer, and Sander, a school teacher. He went to Southfield-Lathrup High School and then Michigan University from which he got a juris doctor and more information click here.

Lefkofsky entrepreneurial journey started at Michigan University. He sold carpets to the students. Later on, he shifted to clothes business in partnership with his college mate, Brad Keywell in 1993. They branded their newly acquired company Brandon Apparel and learn more about Eric.

An increase in cancer cases prompted Lefkofsky’s co-founded company, Tempus, to look for ways of modernizing cancer treatment. The idea was born when Lefkofsky realized that all the data collected from cancer patients was not being used well in cancer diagnosis. Tempus developed a way through which patients clinical data would be combined with their genetic information to offer treatment.

Initially, the company faced a challenge regarding how cancer patients’ data would be collected from the progress reports. To curb this, they developed software for processing optical characters from physician’s notes. All the information gathered aids in making informed decisions by doctors and Eric’s lacrosse camp.

The technology behind all this is called human genome sequencing. A few years ago, the process used to be a preserve of the wealthy due to high costs involved. Luckily, current technological changes have forced the prices to come down. When the process started back in 2003, the whole process cost $ 100 million. Currently, it can be done at $ 5,000 with the prices being projected to go down further, thanks to companies like Tempus.

The human genes hold critical information that can unlock the ability to fight fatal diseases like cancer. When a huge database is formed regarding patients genetic information, coming with a solution to cancer gets a step closer. Doctors, through such platform as Tempus’, will be able to make real time decisions and determine which medicine would work well. Constant update of information will be not only useful in finding a cure for cancer, but also several other diseases and conditions.